Soligenix, Inc.

SNGX Nasdaq SEC CIK 812796
Follow Soligenix Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$1.1M +55.8% vs same quarter last year
EPS, diluted −$0.05 +91.4% vs same quarter last year
Operating cash flow −$1.4M +51.4% vs same quarter last year
Operating income −$1.4M +46.7% vs same quarter last year
Net income by quarter
−$3M
−$3M
−$2.7M
−$2.5M
−$2.9M
−$2.8M
−$2M
−$1.1M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$20M−$10M$0$10M$20MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25-−$11.1M
FY24$119.4K−$8.3M
FY23$839.4K−$6.1M
FY22$948.9K−$13.8M
FY21$824.3K−$12.6M
FY20$2.4M−$17.7M
FY19$4.6M−$9.4M
FY18$5.2M−$8.9M
FY17$5.4M−$7.1M
FY16$10.4M−$3.2M
FY15$8.8M−$7.8M
FY14$7M−$6.7M
FY13$3.2M−$10.1M
FY12$3.1M−$4.2M
FY11$7.7M−$2.4M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−8000%−6000%−4000%−2000%0%2000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY25---
FY240%−7907.7%−6953.1%
FY2311.6%−917.1%−726.7%
FY2242%−1500.6%−1454.1%
FY2111.6%−1589.2%−1522.7%
FY2022.8%−787.7%−749.7%
FY1922.9%−227.7%−202.1%
FY1812.3%−172.8%−169.8%
FY1720.7%−139.8%−131.6%
FY1619.3%−54.6%−31.1%
FY1521.5%−81.1%−89.3%
FY1424.6%−152.8%−95.2%
FY1321.1%−222%−312%
FY1217.5%−149.2%−132.4%
FY1172.5%−38.6%−31%
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Soligenix
  • Healthcare median
−8000%−6000%−4000%−2000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearSoligenixHealthcare median
FY25-−30.6%
FY24−6953.1%−47%
FY23−726.7%−58%
FY22−1454.1%−80.4%
FY21−1522.7%−71.9%
FY20−749.7%−62.2%
FY19−202.1%−46.3%
FY18−169.8%−49.6%
FY17−131.6%−45.9%
FY16−31.1%−36%
FY15−89.3%−38.4%
FY14−95.2%−35.5%
FY13−312%−37.1%
FY12−132.4%−29.1%
FY11−31%−27.9%